Production of a monoclonal antibody targeting the SARS-CoV-2 Omicron spike protein and analysis of SARS-CoV-2 Omicron mutations related to monoclonal antibody resistance
- 21 November 2024
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 27 (3) , 105461
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2022M3A9I2082292)
This publication has 70 references indexed in Scilit:
- A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethalityJournal of Medical Virology, 2024
- The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariantsMedcomm, 2023
- In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike proteinJournal of Medical Virology, 2023
- The outbreak of the Ebola virus: Concerns for the animal‐to‐human spilloverJournal of Medical Virology, 2022
- De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV‐2 spike receptor binding domain (RBD)Proteins: Structure, Function, and Bioinformatics, 2022
- Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron VariantJAMA, 2022
- Natural infections of SARS‐CoV‐2 increased in animals: How should humans interact with animals?Journal of Medical Virology, 2022
- SARS‐CoV‐2 and dengue virus co‐infection: Epidemiology, pathogenesis, diagnosis, treatment, and managementReviews in Medical Virology, 2022
- Charge Matters: Mutations in Omicron Variant Favor Binding to CellsChemBioChem, 2022
- Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccinesJournal of Medical Virology, 2022